Literature DB >> 27450031

Hypofrontality and Posterior Hyperactivity in Early Schizophrenia: Imaging and Behavior in a Preclinical Model.

Gen Kaneko1, Basavaraju G Sanganahalli1, Stephanie M Groman2, Helen Wang1, Daniel Coman1, Jyotsna Rao1, Peter Herman1, Lihong Jiang1, Katherine Rich2, Robin A de Graaf3, Jane R Taylor2, Fahmeed Hyder4.   

Abstract

BACKGROUND: Schizophrenia is a debilitating neuropsychiatric disorder typically diagnosed from late adolescence to adulthood. Subthreshold behavioral symptoms (e.g., cognitive deficits and substance abuse) often precede the clinical diagnosis of schizophrenia. However, these prodromal symptoms have not been consistently associated with structural and functional brain biomarkers, limiting the chance of early diagnosis of schizophrenia.
METHODS: Using an extensively multimodal range of magnetic resonance methods (for anatomy, metabolism, and function), we screened early biomarkers in a methylazoxymethanol acetate (MAM) rat model of schizophrenia and saline-treated control (SHAM) rats, in conjunction with immunohistochemistry, myelin staining, and a novel three-choice, reversal-learning task to identify early behavioral markers corresponding the subthreshold symptoms.
RESULTS: MAM (vs. SHAM) rats had lower/higher structural connectivity in anterior/posterior corpus callosum. The orbitofrontal cortex of MAM rats showed lower resting-state functional magnetic resonance imaging functional connectivity in conjunction with lower neuronal density, lower glucose oxidation, and attenuated neurotransmission (hypofrontality). In contrast, these measures were all higher in visual cortex of MAM rats (posterior hyperactivity), which might parallel perceptual problems in schizophrenia. In behavioral studies, MAM (vs. SHAM) rats displayed abnormal orbitofrontal cortex-mediated decision-making processes, resulting in a novel reward-sensitive hyperflexible phenotype, which might reflect vulnerability of prodromal patients to substance abuse.
CONCLUSIONS: We identified two novel biomarkers of early schizophrenia in a preclinical rat model: hypofrontality associated with the hyperflexible phenotype, and posterior hyperactivity. Because each of these magnetic resonance methods is clinically translatable, these markers could contribute to early diagnosis and the development of novel therapies of schizophrenia.
Copyright © 2016 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Decision making; GABA; Glucose oxidation; Glutamate; Reinforcement learning; fMRI

Mesh:

Substances:

Year:  2016        PMID: 27450031      PMCID: PMC5130616          DOI: 10.1016/j.biopsych.2016.05.019

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  73 in total

1.  Comparison of alpha-chloralose, medetomidine and isoflurane anesthesia for functional connectivity mapping in the rat.

Authors:  Kathleen A Williams; Matthew Magnuson; Waqas Majeed; Stephen M LaConte; Scott J Peltier; Xiaoping Hu; Shella D Keilholz
Journal:  Magn Reson Imaging       Date:  2010-04-24       Impact factor: 2.546

2.  Neonatal origins of schizophrenia.

Authors:  M Cannon; R M Murray
Journal:  Arch Dis Child       Date:  1998-01       Impact factor: 3.791

3.  Childhood behaviour, psychotic symptoms and psychosis onset in young people at high risk of schizophrenia: early findings from the edinburgh high risk study.

Authors:  P M Miller; M Byrne; A Hodges; S M Lawrie; E C Johnstone
Journal:  Psychol Med       Date:  2002-01       Impact factor: 7.723

Review 4.  State of the art direct 13C and indirect 1H-[13C] NMR spectroscopy in vivo. A practical guide.

Authors:  Robin A de Graaf; Douglas L Rothman; Kevin L Behar
Journal:  NMR Biomed       Date:  2011-08-23       Impact factor: 4.044

5.  Effect of antipsychotics on spontaneous hyperactivity and hypersensitivity to MK-801-induced hyperactivity in rats prenatally exposed to methylazoxymethanol.

Authors:  Gwenaëlle Le Pen; Thérèse M Jay; Marie-Odile Krebs
Journal:  J Psychopharmacol       Date:  2010-11-18       Impact factor: 4.153

6.  Peripubertal diazepam administration prevents the emergence of dopamine system hyperresponsivity in the MAM developmental disruption model of schizophrenia.

Authors:  Yijuan Du; Anthony A Grace
Journal:  Neuropsychopharmacology       Date:  2013-04-23       Impact factor: 7.853

Review 7.  A time of change: behavioral and neural correlates of adolescent sensitivity to appetitive and aversive environmental cues.

Authors:  Leah H Somerville; Rebecca M Jones; B J Casey
Journal:  Brain Cogn       Date:  2009-08-19       Impact factor: 2.310

8.  Neurodevelopment of C57B/L6 mouse brain assessed by in vivo diffusion tensor imaging.

Authors:  Halima Chahboune; Laura R Ment; William B Stewart; Xiaoxian Ma; Douglas L Rothman; Fahmeed Hyder
Journal:  NMR Biomed       Date:  2007-05       Impact factor: 4.044

9.  Childhood behavioral precursors of adult symptom dimensions in schizophrenia.

Authors:  K M Baum; E F Walker
Journal:  Schizophr Res       Date:  1995-08-01       Impact factor: 4.939

10.  Marked hypofrontality in clozapine-responsive patients.

Authors:  V Molina; J Sanz; F Sarramea; T Palomo
Journal:  Pharmacopsychiatry       Date:  2007-07       Impact factor: 5.788

View more
  13 in total

1.  Alterations of Parenchymal Microstructure, Neuronal Connectivity, and Cerebrovascular Resistance at Adolescence after Mild-to-Moderate Traumatic Brain Injury in Early Development.

Authors:  Maxime Parent; Ying Li; Vijayalakshmi Santhakumar; Fahmeed Hyder; Basavaraju G Sanganahalli; Sridhar S Kannurpatti
Journal:  J Neurotrauma       Date:  2018-08-13       Impact factor: 5.269

Review 2.  Quantitative Rodent Brain Receptor Imaging.

Authors:  Kristina Herfert; Julia G Mannheim; Laura Kuebler; Sabina Marciano; Mario Amend; Christoph Parl; Hanna Napieczynska; Florian M Maier; Salvador Castaneda Vega; Bernd J Pichler
Journal:  Mol Imaging Biol       Date:  2020-04       Impact factor: 3.488

3.  Suppression of Methamphetamine Self-Administration by Ketamine Pre-treatment Is Absent in the Methylazoxymethanol (MAM) Rat Model of Schizophrenia.

Authors:  Jana Ruda-Kucerova; Zuzana Babinska; Tibor Stark; Vincenzo Micale
Journal:  Neurotox Res       Date:  2017-04-18       Impact factor: 3.911

4.  Nicotine Self-administration Is Not Increased in the Methylazoxymethanol Acetate Rodent Model of Schizophrenia.

Authors:  Jillian J Weeks; Laura E Rupprecht; Anthony A Grace; Eric C Donny; Alan F Sved
Journal:  Nicotine Tob Res       Date:  2020-02-06       Impact factor: 4.244

Review 5.  Explaining Delusions: Reducing Uncertainty Through Basic and Computational Neuroscience.

Authors:  Erin J Feeney; Stephanie M Groman; Jane R Taylor; Philip R Corlett
Journal:  Schizophr Bull       Date:  2017-03-01       Impact factor: 9.306

6.  Small loci of astroglial glutamine synthetase deficiency in the postnatal brain cause epileptic seizures and impaired functional connectivity.

Authors:  Maxwell G Farina; Mani Ratnesh S Sandhu; Maxime Parent; Basavaraju G Sanganahalli; Matthew Derbin; Roni Dhaher; Helen Wang; Hitten P Zaveri; Yun Zhou; Niels C Danbolt; Fahmeed Hyder; Tore Eid
Journal:  Epilepsia       Date:  2021-09-18       Impact factor: 5.864

7.  Current Status of Our Understanding for Brain Integrated Functions and its Energetics.

Authors:  Anjani Kumar Tiwari; Anupriya Adhikari; Lokesh Chandra Mishra; Abhishek Srivastava
Journal:  Neurochem Res       Date:  2022-06-11       Impact factor: 4.414

8.  Kaempferol Treatment after Traumatic Brain Injury during Early Development Mitigates Brain Parenchymal Microstructure and Neural Functional Connectivity Deterioration at Adolescence.

Authors:  Maxime Parent; Jyothsna Chitturi; Vijayalakshmi Santhakumar; Fahmeed Hyder; Basavaraju G Sanganahalli; Sridhar S Kannurpatti
Journal:  J Neurotrauma       Date:  2020-02-06       Impact factor: 5.269

9.  Mapping Theme Trends and Knowledge Structure of Magnetic Resonance Imaging Studies of Schizophrenia: A Bibliometric Analysis From 2004 to 2018.

Authors:  Li Duan; Gang Zhu
Journal:  Front Psychiatry       Date:  2020-02-07       Impact factor: 4.157

Review 10.  Magnetic Resonance Spectroscopy in Schizophrenia: Evidence for Glutamatergic Dysfunction and Impaired Energy Metabolism.

Authors:  João M N Duarte; Lijing Xin
Journal:  Neurochem Res       Date:  2018-04-03       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.